ASCO urges more enrollment in Phase I trials

The American Society of Clinical Oncology published an updated policy statement in the Journal of Clinical Oncology that proposes strategies to boost patient enrollment in Phase I cancer trials.

ASCO argued that the development of molecularly targeted agents, biomarker tests and more efficient trial designs have increased the therapeutic potential of Phase I studies. ...